GAMMA Investing LLC reduced its stake in Xylem Inc. (NYSE:XYL – Free Report) by 11.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,285 shares of the industrial products company’s stock after selling 407 shares during the quarter. GAMMA Investing LLC’s holdings in Xylem were worth $381,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. State Street Corp increased its holdings in shares of Xylem by 1.9% during the third quarter. State Street Corp now owns 10,329,494 shares of the industrial products company’s stock valued at $1,394,792,000 after acquiring an additional 189,820 shares in the last quarter. Geode Capital Management LLC boosted its stake in Xylem by 1.0% in the 3rd quarter. Geode Capital Management LLC now owns 5,668,755 shares of the industrial products company’s stock worth $762,804,000 after purchasing an additional 54,877 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of Xylem by 1.0% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 3,449,307 shares of the industrial products company’s stock valued at $465,760,000 after buying an additional 32,645 shares during the last quarter. Swedbank AB increased its position in shares of Xylem by 22.8% during the third quarter. Swedbank AB now owns 2,991,583 shares of the industrial products company’s stock valued at $403,953,000 after acquiring an additional 554,609 shares in the last quarter. Finally, Impax Asset Management Group plc raised its holdings in Xylem by 1.0% in the 3rd quarter. Impax Asset Management Group plc now owns 1,677,816 shares of the industrial products company’s stock worth $226,555,000 after acquiring an additional 15,825 shares during the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Price Performance
Shares of Xylem stock opened at $116.88 on Tuesday. The stock’s fifty day moving average is $122.45 and its 200 day moving average is $129.97. Xylem Inc. has a one year low of $109.39 and a one year high of $146.08. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.42 and a current ratio of 1.96. The stock has a market cap of $28.40 billion, a P/E ratio of 34.18, a P/E/G ratio of 2.22 and a beta of 1.06.
Xylem Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 24th. Stockholders of record on Tuesday, November 26th were paid a $0.36 dividend. The ex-dividend date was Tuesday, November 26th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 1.23%. Xylem’s dividend payout ratio (DPR) is presently 42.11%.
Analyst Upgrades and Downgrades
XYL has been the subject of a number of research analyst reports. TD Cowen reduced their target price on Xylem from $138.00 to $125.00 and set a “hold” rating for the company in a report on Wednesday, November 6th. Wolfe Research reissued a “peer perform” rating on shares of Xylem in a research report on Thursday, December 12th. Citigroup raised shares of Xylem from a “neutral” rating to a “buy” rating and raised their price target for the company from $135.00 to $148.00 in a report on Monday, December 9th. Stifel Nicolaus lowered their price objective on shares of Xylem from $172.00 to $166.00 and set a “buy” rating on the stock in a research report on Wednesday, December 11th. Finally, Robert W. Baird cut their target price on shares of Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. Three research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $152.20.
Check Out Our Latest Stock Report on Xylem
Xylem Profile
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
- Five stocks we like better than Xylem
- How to Invest in the FAANG Stocks
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Most Volatile Stocks, What Investors Need to Know
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.